Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-

The Lancet: Gastroenterology & Hepatology

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2uswYhZ
via IFTTT